查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830959

無針給藥設備市場

Needle-Free Drug Delivery Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

無針給藥裝置市場預計將從 2024 年的 160.1 億美元成長到 2031 年的 284.2 億美元，2025 年至 2031 年期間的年複合成長率(CAGR) 為 8.5%。推動無針給藥裝置市場發展的關鍵趨勢包括策略性舉措的增加和醫療保健整合軟體的採用。

無針給藥設備市場分析：針頭有感染多種疾病的風險，包括愛滋病毒 (HIV)，如果操作不當，還可能造成傷害。根據《MEDICSEN：用於無痛給藥的無針智慧貼片》一文，美國每天有超過 2,000 人遭受針刺傷，每年造成超過 30 億美元的相關費用。無針給藥設備的採用可顯著降低此類傷害和疾病的風險。因此，針刺傷發生率的上升和治療費用的增加正在推動無針給藥設備市場的成長。

無針給藥裝置市場概況

無針給藥方法包括動力噴霧器、噴射注射器、吸入器和皮膚貼片。這項技術可以緩解患者因針頭引起的焦慮。無針裝置可有效注射多種藥物，並且與傳統針頭生物等效。無針給藥系統的優點在於減輕疼痛、快速給藥、無需針頭處置以及可自行給藥等，這些都是推動此類裝置需求成長的主要動力。

戰略洞察

無針給藥設備市場的促進因素與機會

慢性病和生活方式紊亂發病率上升將使市場受益

心臟病、糖尿病和癌症等慢性疾病是全球死亡和殘疾的主要原因之一。根據美國疾病管制與預防中心 (CDC) 的數據，2021 年約有 3,840 萬美國人被診斷出患有糖尿病。為了控制糖尿病，需要定期將胰島素注射到皮下層。糖尿病的日益普及推動了胰島素注射的需求。各公司越來越重視開發無針胰島素輸送系統，以防止針刺傷。例如，Medicsen 正在研發 SmartPatch，以提高胰島素輸送效率。

家庭醫療保健日益受到青睞—無針給藥市場的機會

從醫院和長期護理機構向家庭護理環境的轉變，增強了患者與醫療服務提供者之間更佳、更一致、更及時的互動，而雲端和行動醫療設備的日益普及，則促進了這一轉變。在發展中國家，接受家庭治療的患者數量歷來有限。與電子健康記錄 (EHR) 整合的智慧貼片和噴射注射器使醫生能夠遠端監控藥物劑量。借助無針給藥設備，患者可以按照醫療服務提供者的處方，方便地自行用藥。因此，對家庭醫療保健的日益重視以及對技術先進產品的採用預計將在預測期內為市場創造成長機會。

無針給藥裝置市場細分分析報告

對無針藥物輸送裝置市場進行分析的關鍵部分包括類型和應用。

依類型分類，無針給藥裝置市場分為吸入器、噴射注射器、新型針頭、透皮貼片等。噴射注射器在2023年佔據了最大的市場。依應用分類，市場分為胰島素輸送、疫苗接種、疼痛管理等。胰島素輸送領域在2023年佔據了市場主導地位。無針給藥裝置市場佔有率的地理分析：無針給藥裝置市場報告的地理範圍分為五個區域：北美、亞太地區、歐洲、中東和非洲以及南美。

2023年，北美是無針給藥設備市場的領先地區。該地區的成長動力源於生物製藥和生物技術公司對罕見疾病藥物的需求不斷成長、主要市場參與者的加入、新產品的推出、針刺傷發生率的上升，以及學術機構和製藥公司大力投入的研發。此外，預計未來幾年亞太地區將呈現最高的複合年成長率。

無針給藥裝置市場的最新發展與新聞

無針給藥設備市場的評估是基於從一手資料和二手資料中收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。以下是無針給藥設備市場的一些最新發展和策略：

NovaXS 成立於加州大學柏克萊分校，已開發出正在申請專利的 Telosis 技術，可在短短 0.3 秒內無需針頭即可注射細流藥物，並分析注射資料以促進更明智的健康決策。 （資料來源：NovaXS Biotech，新聞稿，2022 年）NuGen Medical Devices Inc. 在加拿大推出了 InsuJet 設備。 SOL-MILLENNIUM 醫療集團作為參展商參加了 2022 年加拿大糖尿病協會/加拿大內分泌與代謝學會 (CSEM) 專業會議，並在會上向加拿大市場推出了 InsuJet 產品。 （資料來源：NuGen Medical Devices Inc，公司網站，2022 年）無針給藥裝置市場報告的範圍無針給藥裝置市場報告的覆蓋範圍和可交付成果題為“無針給藥裝置市場規模和預測（2023-2031 年）”的報告對市場進行了全面的分析，涵蓋以下領域：

範圍內所有關鍵市場領域的全球、區域和國家層面的市場規模和預測市場動態，例如促進因素、限制因素和重大機會關鍵的未來趨勢深入的 PEST 和 SWOT 分析全球和區域市場分析，重點介紹關鍵趨勢、主要參與者、法規和最新發展行業格局和競爭分析，包括市場集中度、熱圖分析、知名參與者和最新進展詳細的公司簡介

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：無針給藥設備市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：無針給藥裝置市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：無針給藥裝置市場－全球市場分析

  • 無針給藥裝置 - 全球市場概覽
  • 無針給藥裝置－全球市場及2031年預測

第7章：無針給藥裝置市場-收入分析-按類型，2021-2031

  • 概述
  • 噴射器
  • 透皮貼劑
  • 吸入器
  • 新型無針
  • 其他

第 8 章：無針給藥設備市場 - 收入分析 - 按應用，2021-2031 年

  • 概述
  • 疫苗接種
  • 疼痛管理
  • 胰島素輸送
  • 其他

第9章：無針給藥裝置市場-收入分析，2021-2031-地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第10章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 11 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 12 章：無針給藥裝置市場 - 主要公司簡介

  • NuGen Medical Devices
  • NovaXS Biotech
  • GlaxoSmithKline
  • AstraZeneca
  • Roche
  • Boehringer Ingelheim
  • Merck
  • Cipla
  • Novartis
  • Teva Pharmaceuticals
  • Omron Healthcare
  • Sumitomo Pharma Co. Ltd

第 13 章：附錄

簡介目錄
Product Code: TIPHE100001168

The market for needle-free drug delivery devices is anticipated to grow from US$ 16.01 billion in 2024 to US$ 28.42 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.5% during the period from 2025 to 2031. Key trends driving the needle-free drug delivery devices market include an increase in strategic initiatives and the adoption of healthcare integration software.

Analysis of the Needle-Free Drug Delivery Devices Market

Needles pose risks of various diseases, including HIV, and can cause injuries if not handled with care. According to the article "MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY", more than 2,000 individuals in the US experience needlestick injuries daily, resulting in over US$ 3 billion in related costs each year. The adoption of needle-free drug delivery devices significantly reduces the risk of such injuries and diseases. Consequently, the rising incidence of needlestick injuries and increased spending on treatment are propelling the growth of the needle-free drug delivery devices market.

Overview of the Needle-Free Drug Delivery Devices Market

Needle-free drug delivery methods include power sprays, jet injectors, inhalers, and skin patches. This technology alleviates patient anxiety associated with needles. Needle-free devices provide effective injections for a variety of medications and are bioequivalent to traditional needles. The benefits of needle-free delivery systems, such as reduced pain, rapid administration, elimination of needle disposal issues, and the ability for self-administration, are primarily driving the rising demand for these devices.

Strategic Insights

Drivers and Opportunities in the Needle-Free Drug Delivery Devices Market

Increasing Incidence of Chronic Diseases and Lifestyle Disorders to Benefit the Market

Chronic conditions like heart disease, diabetes, and cancer are among the leading causes of mortality and disability globally. According to the Centers for Disease Control and Prevention (CDC), approximately 38.4 million Americans were diagnosed with diabetes in 2021. To manage diabetes, insulin is regularly injected into the subcutaneous layer. The growing prevalence of diabetes is driving the demand for insulin injections. Companies are increasingly focusing on developing needle-free insulin delivery systems to prevent needlestick injuries. For example, Medicsen is working on the SmartPatch to enhance insulin delivery efficiency.

Growing Preference for Home Healthcare - A Chance for the Needle-Free Drug Delivery Market

The transition from hospitals and long-term care facilities to home care settings enhances the potential for improved, consistent, and timely interactions between patients and healthcare providers, facilitated by the increasing use of cloud-based and mobile medical devices. In developing nations, the number of patients receiving home therapy has historically been limited. Smart patches and jet injectors that integrate with electronic health records (EHR) enable doctors to monitor dosages remotely. With needle-free drug delivery devices, patients can conveniently self-administer their medications as prescribed by their healthcare providers. Therefore, the rising emphasis on home healthcare and the adoption of technologically advanced products are expected to create growth opportunities for the market during the forecast period.

Segmentation Analysis of the Needle-Free Drug Delivery Devices Market Report

Key segments contributing to the analysis of the needle-free drug delivery devices market include type and application.

By type, the needle-free drug delivery devices market is categorized into inhalers, jet injectors, novel needles, transdermal patches, and others. The jet injectors segment accounted for the largest market share in 2023.By application, the market is divided into insulin delivery, vaccination, pain management, and others. The insulin delivery segment led the market in 2023.

Geographical Analysis of the Needle-Free Drug Delivery Devices Market Share

The geographical scope of the needle-free drug delivery devices market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America.

North America was the leading region in the needle-free drug delivery devices market in 2023. The growth in this region is driven by the rising demand for medications for rare diseases from biopharmaceutical and biotechnology firms, the presence of major market players, an increase in product launches, a growing incidence of needlestick injuries, and extensive research and development efforts by academic institutions and pharmaceutical companies. Additionally, the Asia Pacific region is expected to exhibit the highest CAGR in the coming years.

Recent Developments and News in the Needle-Free Drug Delivery Devices Market

The evaluation of the needle-free drug delivery devices market is based on qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Below are some recent developments and strategies in the needle-free drug delivery devices market:

NovaXS, established at the University of California, Berkeley, has developed its patent-pending Telosis technology, which administers a narrow stream of medication without a needle in just 0.3 seconds and analyzes injection data to facilitate smarter health decisions. (Source: NovaXS BIotech, Press Release, 2022)NuGen Medical Devices Inc. introduced InsuJet devices in Canada. SOL-MILLENNIUM Medical Group participated as an exhibitor at the 2022 Diabetes Canada/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference, where it launched the InsuJet product for the Canadian market. (Source: NuGen Medical Devices Inc, Company Website, 2022

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Needle-Free Drug Delivery Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Needle-Free Drug Delivery Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Needle-Free Drug Delivery Devices Market - Global Market Analysis

  • 6.1 Needle-Free Drug Delivery Devices - Global Market Overview
  • 6.2 Needle-Free Drug Delivery Devices - Global Market and Forecast to 2031

7. Needle-Free Drug Delivery Devices Market - Revenue Analysis (USD Million) - By Type, 2021-2031

  • 7.1 Overview
  • 7.2 Jet Injectors
  • 7.3 Transdermal Patch
  • 7.4 Inhaler
  • 7.5 Novel Needle-free
  • 7.6 Others

8. Needle-Free Drug Delivery Devices Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 8.1 Overview
  • 8.2 Vaccination
  • 8.3 Pain Management
  • 8.4 Insulin Delivery
  • 8.5 Others

9. Needle-Free Drug Delivery Devices Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Needle-Free Drug Delivery Devices Market Overview
    • 9.1.2 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts to 2031
    • 9.1.3 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Type
    • 9.1.4 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Application
    • 9.1.5 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Countries
      • 9.1.5.1 United States Needle-Free Drug Delivery Devices Market
        • 9.1.5.1.1 United States Needle-Free Drug Delivery Devices Market, by Type
        • 9.1.5.1.2 United States Needle-Free Drug Delivery Devices Market, by Application
      • 9.1.5.2 Canada Needle-Free Drug Delivery Devices Market
        • 9.1.5.2.1 Canada Needle-Free Drug Delivery Devices Market, by Type
        • 9.1.5.2.2 Canada Needle-Free Drug Delivery Devices Market, by Application
      • 9.1.5.3 Mexico Needle-Free Drug Delivery Devices Market
        • 9.1.5.3.1 Mexico Needle-Free Drug Delivery Devices Market, by Type
        • 9.1.5.3.2 Mexico Needle-Free Drug Delivery Devices Market, by Application
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 Italy
    • 9.2.4 Spain
    • 9.2.5 United Kingdom
    • 9.2.6 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Middle East and Africa
    • 9.4.1 South Africa
    • 9.4.2 Saudi Arabia
    • 9.4.3 U.A.E
    • 9.4.4 Rest of Middle East and Africa
  • 9.5 South and Central America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of South and Central America

10. Industry Landscape

  • 10.1 Mergers and Acquisitions
  • 10.2 Agreements, Collaborations, Joint Ventures
  • 10.3 New Product Launches
  • 10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Positioning and Concentration

12. Needle-Free Drug Delivery Devices Market - Key Company Profiles

  • 12.1 NuGen Medical Devices
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 NovaXS Biotech
  • 12.3 GlaxoSmithKline
  • 12.4 AstraZeneca
  • 12.5 Roche
  • 12.6 Boehringer Ingelheim
  • 12.7 Merck
  • 12.8 Cipla
  • 12.9 Novartis
  • 12.10 Teva Pharmaceuticals
  • 12.11 Omron Healthcare
  • 12.12 Sumitomo Pharma Co. Ltd

13. Appendix

  • 13.1 Glossary
  • 13.2 About The Insight Partners
  • 13.3 Market Intelligence Cloud